CBD Nutraceuticals Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type (CBD Tinctures, Capsules & Softgels, CBD Gummies, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region, and By Competition 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 5.09 Billion
CAGR (2026-2031)	12.43%
Fastest Growing Segment	Online Pharmacies
Largest Market	North America
Market Size (2031)	USD 10.28 Billion

Market Overview

The Global CBD Nutraceuticals Market will grow from USD 5.09 Billion in 2025 to USD 10.28 Billion by 2031 at a 12.43% CAGR. CBD nutraceuticals encompass a range of wellness products, including dietary supplements, functional foods, and beverages infused with cannabidiol derived from industrial hemp, designed to provide therapeutic benefits such as stress relief and improved sleep without psychoactive effects. The market’s expansion is primarily supported by a fundamental shift in consumer behavior toward preventative healthcare and a growing preference for natural, plant-based alternatives to traditional pharmaceuticals. According to the U.S. Hemp Roundtable, the United States hemp industry, which serves as a major component of the global market, generated approximately $28.4 billion in revenue in 2024.

However, a significant challenge impeding broader market expansion is the persistent regulatory fragmentation across international jurisdictions. Inconsistent legal frameworks regarding permissible CBD concentrations, labeling requirements, and classification as either food or medicine create a complex compliance landscape that complicates global trade and restricts access to essential banking and payment processing services for manufacturers.

Key Market Drivers

Rising Consumer Awareness of Therapeutic Health Benefits is fundamentally reshaping the Global CBD Nutraceuticals Market, transitioning cannabidiol from a niche commodity to a mainstream wellness staple. As public understanding of the non-psychoactive properties of hemp evolves, a growing demographic is actively seeking plant-based alternatives for anxiety, sleep regulation, and chronic pain management. This shift in consumer sentiment is quantified by high adoption rates; according to Forbes Health, April 2024, in the 'CBD Statistics, Data And Use In 2024' article, 60% of U.S. adults either use or have tried a CBD product. This widespread acceptance is encouraging manufacturers to innovate beyond simple tinctures, developing targeted nutraceutical formulations that cater to an increasingly educated and health-conscious customer base.

Expansion of Mainstream Retail and E-Commerce Distribution Channels serves as the second critical engine for market growth, effectively dismantling barriers to access. The migration of CBD products from specialized dispensaries to large-scale retailers has significantly enhanced brand visibility and consumer trust. A prime example of this trend occurred when, according to Charlotte's Web Holdings Inc., November 2024, in the 'Reports 2024 Third Quarter Financial Results', the company expanded its retail presence through a partnership with Walmart, introducing its CBD topicals to 827 additional stores. This strategic placement normalizes the category within the standard shopping experience. Furthermore, indicating the improving operational stability within the sector, according to CV Sciences, Inc., November 2024, in the 'Reports Third Quarter 2024 Financial Results', the company recognized a gross margin of 46.0% for the quarter, reflecting a maturing market structure capable of sustaining profitability despite complex regulatory environments.

Download Free Sample Report

Key Market Challenges

Regulatory fragmentation represents the most formidable barrier currently impeding the expansion of the global CBD nutraceuticals market. The absence of a unified legal framework forces manufacturers to navigate a complex patchwork of contradictory rules, where permissible THC concentrations and product classifications differ drastically between jurisdictions. This inconsistency disrupts international supply chains and significantly increases compliance costs, as companies must continually reformulate products and alter packaging to meet disparate regional standards. Furthermore, the ambiguous legal status of these products in major economies creates a high-risk environment that discourages institutional investment and restricts access to essential banking services, thereby stalling capital flow and innovation.

The impact of this regulatory instability is severe, creating existential risks for established market players. According to the U.S. Hemp Roundtable, in 2024, restrictive legislative amendments proposed due to the lack of clear federal definitions threatened to effectively ban approximately 95% of all hemp extract products sold in the marketplace. This high level of uncertainty prevents companies from executing long-term growth strategies and limits the industry's ability to transition from a niche sector to a fully integrated component of the global wellness economy.

Key Market Trends

The Emergence of Minor Cannabinoids like CBN and CBG in Product Lines is actively redefining product differentiation strategies within the sector, moving beyond generic wellness claims to target specific physiological conditions. Manufacturers are increasingly isolating minor cannabinoids to formulate distinct sleep and focus aids, capitalizing on the "entourage effect" where these compounds work synergistically with CBD to enhance therapeutic outcomes. This shift toward ingredient sophistication is exemplified by recent product innovations designed to address persistent consumer health issues such as insomnia. According to Charlotte's Web Holdings, Inc., March 2024, in the 'Charlotte's Web Launches Stay Asleep CBN Gummies' press release, the company introduced a new condition-specific formulation delivering a precise 20 mg dose of CBN, clinically targeted to support consumers suffering from sleep disturbances.

The Increasing Dominance of Gummy and Edible Formats represents a parallel evolution in consumer preference, prioritizing convenience and palatability over traditional sublingual tinctures. This trend is compelling companies to restructure their portfolios, as consumers favor familiar confectionery-style delivery systems that integrate seamlessly into daily routines without the medicinal stigma associated with oils or capsules. This format preference is translating into robust financial performance for brands that prioritize edible innovations. According to Flora Growth Corp., August 2024, in the 'Reports Second Quarter 2024 Financial Results', the company's JustCBD subsidiary maintained a resilient gross profit margin of 34% on sales of $4.4 million, a performance explicitly driven by the strong sales volume of their gummy product lines.

Segmental Insights

The Online Pharmacies segment is currently the fastest-growing category within the Global CBD Nutraceuticals Market, driven by a fundamental shift in consumer preference toward digital healthcare solutions. This rapid expansion is primarily attributed to the convenience and discretion that digital platforms offer for purchasing therapeutic products. Furthermore, online pharmacies provide superior access to critical product information, including third-party laboratory results and Certificates of Analysis, which addresses growing consumer demand for transparency and safety. The ability to offer a diverse inventory of specialized formulations without physical shelf constraints further strengthens the competitive position of this segment.

Regional Insights

North America maintains a leading position in the global CBD nutraceuticals market, primarily driven by favorable legislative frameworks and high consumer demand for wellness products. The enactment of the United States 2018 Farm Bill, which legalized commercial hemp production, served as a critical catalyst for regional growth by removing significant legal barriers for manufacturers. This regulatory support allowed companies to expand product distribution networks extensively across the country. Additionally, a well-established retail infrastructure and rising consumer acceptance of plant-based supplements ensure that the region continues to command the largest share of the global market.

Recent Developments

• In November 2024, Tilray Medical, a division of Tilray Brands, Inc., announced the final results of a randomized, placebo-controlled clinical study evaluating the efficacy of an oral cannabis extract for managing chemotherapy-induced nausea and vomiting (CINV). The research, conducted over several years, found that the oral extract, containing a balanced ratio of THC and CBD, significantly improved complete response rates in patients who had not responded adequately to standard anti-nausea treatments. This breakthrough research underscores the potential of cannabinoid-based therapies in oncology supportive care and reinforces the company's commitment to advancing clinical evidence for medical cannabis applications in treating complex medical conditions.
• In November 2024, CV Sciences, Inc. entered into a definitive agreement to acquire Extract Labs, Inc., a prominent manufacturer and distributor of premium hemp-derived cannabinoid products. This strategic acquisition is intended to bolster CV Sciences' position in the global wellness market by integrating Extract Labs' extensive product line, which includes gummies, topicals, and tinctures, as well as its manufacturing capabilities. The transaction is expected to generate operational synergies, expand the company's customer base, and enhance its ability to innovate within the nutraceutical sector. This move follows the company's earlier acquisition of elevated softgel manufacturing assets, further vertically integrating its supply chain.
• In September 2024, CBD Life Sciences, Inc. introduced a new CBD-infused functional beverage product, "Mellow Mornings," a nano-CBD coffee creamer aimed at the growing functional beverage market. The product, available in multiple flavors, utilizes advanced nanotechnology to enhance the bioavailability of cannabidiol, allowing for more efficient absorption by the body compared to traditional formulations. Each bottle contains 1000mg of CBD and is designed to integrate seamlessly into consumers' daily routines. This launch represents the company's effort to capitalize on the increasing consumer demand for convenient, wellness-oriented products that combine the therapeutic benefits of hemp extracts with everyday rituals like coffee consumption.
• In March 2024, Charlotte's Web Holdings, Inc. expanded its product portfolio with the launch of "Stay Asleep" CBN Gummies, a new botanical wellness solution designed to support quality sleep. This product features cannabinol (CBN), a minor cannabinoid derived from the hemp plant, which is distinct from CBD but shares its non-intoxicating properties. The launch was supported by a peer-reviewed, placebo-controlled clinical study demonstrating the formulation's efficacy in reducing sleep disturbances and nighttime awakenings. This development highlights the company's strategic focus on science-backed innovations and the broadening of its offerings beyond traditional CBD products to include other functional hemp compounds.

Key Market Players

• Gaia Botanicals LLC
• CV Sciences, Inc.
• Elixinol LLC
• Garden of Life
• Isodiol International Inc
• Medical Marijuana Inc
• Medterra

By Product Type	By Distribution Channel	By Region
CBD Tinctures Capsules & Softgels CBD Gummies Others	Hospital Pharmacies Retail Pharmacies Online Pharmacies	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global CBD Nutraceuticals Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• CBD Nutraceuticals Market, By Product Type:

• CBD Tinctures
• Capsules & Softgels
• CBD Gummies
• Others

• CBD Nutraceuticals Market, By Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

• CBD Nutraceuticals Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE